PX-102 Uses, Dosage, Side Effects and more
PX-102 is under investigation in clinical trial NCT01998672 (Multiple Ascending Oral Dose Phase I Study With Px-102).
| Trade Name | PX-102 |
| Generic | PX-102 |
| Type | |
| Formula | C29H22Cl3NO4 |
| Weight | Average: 554.85 Monoisotopic: 553.0614413 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
